January 16, 2020
SciDev– January 16, 2020- Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics & Policy in Washington DC, said that despite undoubted progress on AMR in terms of surveillance, awareness and action plans, “the age of privately funded antibiotic development is over unless the economics change radically”.
Invest in a better planet for future generations. Support our work to fight drug resistance, prevent disease spillovers, and improve pandemic preparedness.
Too busy to keep up with the latest scientific literature in global health? Let us summarize it for you with our weekly digest. Sign up here.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |